Literature DB >> 2117726

Survival statistics for multiple primaries in head and neck cancer.

J T Larson1, G L Adams, H A Fattah.   

Abstract

The recognition of a second primary carcinoma in a patient with known head and neck cancer is considered a poor prognostic sign. However, its true implication for patient survival is not known. A retrospective 10-year study showed that second primary malignancies developed in 207 of 875 patients. Second primary malignancies were most commonly associated with glottic index tumors, followed by floor of mouth tumors. The second primary was most likely to occur at a time interval of 1.5 years from diagnosis of the index tumor. Second primary neoplasms were more likely to develop in patients whose original head and neck tumor was stage I or II, or whose histopathology showed well or moderately well differentiation. Patients with head and neck cancer in whom a second upper aerodigestive tract tumor develops have a 75% chance of 1-year survival, but only a 25% chance of 5-year survival. The average time from diagnosis of second primary to the time of death was 2.3 years. If we are to increase the survival time of our patients with head and neck cancer, we must consider that a second primary will develop in one of four patients. We must therefore consider the high risk of second primary malignancy when formulating the original treatment plan for a patient manifesting his or her first head and neck cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2117726     DOI: 10.1177/019459989010300103

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  12 in total

Review 1.  Head and neck cancer stem cells.

Authors:  S Krishnamurthy; J E Nör
Journal:  J Dent Res       Date:  2011-09-20       Impact factor: 6.116

2.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.

Authors:  M P Stokkel; F W ten Broek; G J Hordijk; R Koole; P P van Rijk
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

3.  Prognostic impact of second primary tumors in head and neck cancer.

Authors:  Marta S Patrucco; Marina V Aramendi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-29       Impact factor: 2.503

Review 4.  Chemoprevention of lung cancer.

Authors:  Edward S Kim; Fadlo R Khuri
Journal:  Curr Oncol Rep       Date:  2002-07       Impact factor: 5.075

5.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.

Authors:  J R Grandis; S D Drenning; Q Zeng; S C Watkins; M F Melhem; S Endo; D E Johnson; L Huang; Y He; J D Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 6.  Endoscopic Screening for Second Primary Tumors of the Esophagus Among Head and Neck Cancer Patients.

Authors:  Chen-Shuan Chung; Li-Jen Liao; Chia-Yun Wu; Wu-Chia Lo; Chen-Hsi Hsieh; Tzong-His Lee; Chao-Yu Liu; Deng-Yu Kuo; Pei-Wei Shueng
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

7.  Panendoscopy as a screening procedure for simultaneous primary tumors in head and neck cancer.

Authors:  I J Dhooge; M De Vos; F W Albers; P B Van Cauwenberge
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

8.  Clinical factors related to suspected second primary lung cancer development in patients with head and neck cancer.

Authors:  Eui Bae Kim; Yong Park; Seh Jong Park; Dae Sik Kim; Jee Won Kim; Hee Yun Seo; Hwa Jung Sung; In Keun Choi; Kyong Hwa Park; Sang Cheul Oh; Chul Won Choi; Byung Soo Kim; Yeul Hong Kim; Jun Suk Kim; Sang Won Shin; Chul Yong Kim; Kwang-Yoon Jung
Journal:  Cancer Res Treat       Date:  2008-12-31       Impact factor: 4.679

9.  Second primary tumours in oropharyngeal squamous cell carcinoma.

Authors:  Franz-Josef Kramer; Marcel Janssen; Andre Eckardt
Journal:  Clin Oral Investig       Date:  2004-03-16       Impact factor: 3.573

10.  p53 oncoprotein overexpression correlates with mutagen-induced chromosome fragility in head and neck cancer patients with multiple malignancies.

Authors:  O Gallo; S Bianchi; M L Giovannucci-Uzzielli; R Santoro; S Lenzi; C Salimbeni; M Abbruzzese; E Alajmo
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.